Standout Papers

Improved Survival with Bevacizumab in Advanced Cervical Cancer 2014 2026 2018 2022 987
  1. Improved Survival with Bevacizumab in Advanced Cervical Cancer (2014)
    Krishnansu S. Tewari, Michael W. Sill et al. New England Journal of Medicine

Immediate Impact

18 from Science/Nature 61 standout
Sub-graph 1 of 19

Citing Papers

First-Line Pembrolizumab + Chemotherapy Versus Placebo + Chemotherapy for Persistent, Recurrent, or Metastatic Cervical Cancer: Final Overall Survival Results of KEYNOTE-826
2023 Standout
Cervical cancer therapies: Current challenges and future perspectives
2022 Standout
47 intermediate papers

Works of Harry J. Long being referenced

Bevacizumab for advanced cervical cancer: patient-reported outcomes of a randomised, phase 3 trial (NRG Oncology–Gynecologic Oncology Group protocol 240)
2015
Improved Survival with Bevacizumab in Advanced Cervical Cancer
2014 Standout
and 15 more

Author Peers

Author Last Decade Papers Cites
Harry J. Long 2093 1637 1262 95 4.6k
Naveena Singh 1733 1431 2059 136 4.9k
Rodrigue Mortel 1900 1113 1352 122 4.5k
Leo B. Twiggs 1714 1080 1284 134 4.4k
Katja N. Gaarenstroom 1981 1138 1464 91 4.8k
Sigurd Lax 1586 2083 1133 143 5.8k
Chunqiao Tian 1663 1111 2049 100 4.0k
Brian M. Slomovitz 2331 1339 2042 197 5.0k
D. Scott McMeekin 3206 1232 2688 119 5.4k
Brooke E. Howitt 1779 2045 1947 150 6.4k
Lynda D. Roman 2415 1395 2307 243 5.2k

All Works

Loading papers...

Rankless by CCL
2026